ABSTRACT
The subset of patients reporting chemical sensitivity with neurocognitive complaints usually exhibits specific abnormalities of brain metabolism consistent with neurotoxicity, on imaging with single photon emission computed tomography (SPECT). These recurrent neurotoxic patterns are characterized by a mismatch in tracer uptake between early- and late-phase imaging, multiple hot and cold foci throughout the cortex, temporal asymmetry and increased tracer uptake into the soft tissues and, sometimes, the basal ganglia. Previous studies confirm these neurotoxic findings in patients with neurotoxic chemical exposures and breast implants. Affective processes such as depression do not, alone, show this pattern. These abnormalities in SPECT images correlate with documented neurocognitive impairment. Controlled challenges to ambient chemicals can induce profound neurotoxic changes seen on SPECT imaging in chemically sensitive patients. Detoxification treatment techniques frequently produce significant improvement on brain SPECT brain imaging in these patients. Neurotoxicity appears to be characteristic in many cases of chemical sensitivity.
Subject(s)
Brain/diagnostic imaging , Multiple Chemical Sensitivity/diagnostic imaging , Nervous System Diseases/etiology , Tomography, Emission-Computed, Single-Photon , Brain/metabolism , Breast Implants/adverse effects , Cognition Disorders/etiology , Environmental Exposure , Time FactorsABSTRACT
Single photon emission computed tomography (SPECT) is a useful tool in measuring dynamic brain functioning. Its potential to reveal the physiological mechanisms of neurotoxicity has not been fully explored. In the present study, the SPECT findings for 25 healthy control subjects were compared to the findings for 25 mixed organic solvent exposure subjects. Specific physiological abnormalities related to regional cerebral blood flow activity (rCBF) were revealed. In the early phase of uptake, significantly decreased uptake was found in the mixed organic solvent group; in the late phase of uptake, a significant increase in uptake was found in specific regions of interest. The discovery of this abnormality in brain functioning may be a significant step toward the creation of a biological marker of neurotoxicity. Early detection of neurotoxicity is important in occupational medicine to prevent neurotoxic illnesses in working populations.
Subject(s)
Brain/metabolism , Cerebrovascular Circulation/drug effects , Solvents/pharmacology , Tomography, Emission-Computed, Single-Photon , Adult , Brain/diagnostic imaging , Brain/drug effects , Case-Control Studies , Female , Humans , Male , Middle Aged , Occupational Exposure , Reference ValuesABSTRACT
Chemical sensitivities display a recurrent pattern on scintigraphic examinations of the brain. The pattern can include mismatching between early and late imaging, multiple hot and cold foci distributed throughout the cortex without regard to lobar distribution (salt and pepper pattern), temporal asymmetries, and sometimes increased activity in the basal ganglia. This study used Desert Shield/Desert Storm veterans who present with abnormal neurological and psychological symptoms as a model to exhibit abnormalities by brain scintigraphy. These are typical of those seen in patients with documented exposure to neurotoxic compounds who develop a clinical syndrome that has been termed "chemical sensitivity." Exposure to cocaine, alcohol, and other substances of abuse can result in abnormal scintigrams of the brain using tracers such as [technetium-99m]hexamethylpropyleneoxime. This study used techniques combining regional cerebral blood flow data with delayed distributional data after the intracellular conversion of the tracer into a hydrophilic molecule. In addition to delayed image abnormalities, a mismatch occurs in the regional activity between the two image sets of the veterans. This degree of mismatch was not seen in control subjects who were screened for avoidance of neurotoxic agents. Patterns identified from examinations performed on patients with known exposure to petroleum distillates, pesticides and other materials linked with neurotoxicity were identified in some veterans of the Desert Shield/Desert Storm operation. A single case of repeated examinations on a veteran showed a reversion of these patterns toward normal after therapy. This reversion followed independent assessments of clinical improvement.
Subject(s)
Brain/drug effects , Brain/diagnostic imaging , Multiple Chemical Sensitivity/diagnostic imaging , Adult , Cerebrovascular Circulation/drug effects , Humans , Male , Middle Aged , Organotechnetium Compounds , Oximes , Technetium Tc 99m Exametazime , Tomography, Emission-Computed, Single-PhotonABSTRACT
Separate CNS disease entities are discussed with either the complementary or exclusive indications for radionuclide brain imaging and computerized cranial tomography. Either modality alone has a potential overall precision somewhat in excess of 90% in the localization of cerebral lesions with the effectiveness of each modality differing according to the histology and anatomic location of the lesion. Most investigators agree that the combined application of the two procedures is far superior to their separate use. Routine dynamic isotope studies are essential and in addition, new radiopharmaceuticals and technological advances may improve the radionuclide evaluation of CNS disease. Areas discussed include: primary and secondary CNS neoplasms; acute cerebrovascular accidents; arteriovenous malformations; traumatic cerebrovascular disease; hydrocephalus and dementia; and intracranial inflammatory processes.
